Full metadata record
DC FieldValueLanguage
dc.creatorGarcía-Lacarte, M. (Marcos)-
dc.creatorMartinez, J.A. (José Alfredo)-
dc.creatorZulet, M.A. (María Ángeles)-
dc.creatorMilagro-Yoldi, F.I. (Fermín Ignacio)-
dc.date.accessioned2022-10-19T10:45:09Z-
dc.date.available2022-10-19T10:45:09Z-
dc.date.issued2018-
dc.identifier.citationGarcía-Lacarte, M. (Marcos); Martinez, J.A. (José Alfredo); Zulet, M.A. (María Ángeles); et al. "Implication of miR-612 and miR-1976 in the regulation of TP53 and CD40 and their relationship in the response to specific weight-loss diets". Plos One. 13 (8), 2018, e0201217es_ES
dc.identifier.issn1932-6203-
dc.identifier.urihttps://hdl.handle.net/10171/64521-
dc.description.abstractBackground: Non-coding RNAs (i.e., miRNAs) play a role in the development of obesity and related comorbidities and the regulation of body weight. Objective: To identify candidate miRNA biomarkers throughout omics approaches in order to predict the response to specific weight-loss dietary treatments. Design: Genomic DNA and cDNA isolated from white blood cells of a subset from the RESMENA nutritional intervention study (Low-responders (LR) vs High-responders (HR)) was hybridized in Infinium Human Methylation450 BeadChip and in Illumina Human HT-12 v4 gene expression BeadChips arrays respectively. A bioinformatic prediction of putative target sites of selected miRNAs was performed by applying miRBase algorithms. HEK-293T cells were co-transfected with expression vectors containing the 3'-UTR of candidate genes to validate the binding of miRNAs to its target sites. Results: 134 miRNAs were differentially methylated between HR and LR in the methylation array, whereas 44 miRNAs were differentially expressed between both groups in the expression array. Specifically, miR-1237, miR-1976, miR-642, miR-636, miR-612 and miR-193B were simultaneously hypomethylated and overexpressed in HR. miR-612 and miR-1976 showed greatest differences in methylation and expression levels, respectively. The bioinformatic prediction revealed that TP53 was a putative target gene of miR-612 and CD40 of miR-1976. Moreover, TP53 was downregulated in the expression array when comparing HR vs LR expression levels adjusted by sex, diet, age and baseline weight, and CD40 showed a statistical trend. Furthermore, gene expression levels of TP53 and CD40 in white blood cells, when measured by qPCR, were also downregulated in HR. Finally, miR-612 and miR-1976 potently repressed TP53 and CD40 respectively by targeting its 3'-UTR regions. Conclusion: miR-612 and miR-1976 levels could be prospective biomarkers of response to specific weight-loss diets and might regulate the gene expression of TP53 and CD40.es_ES
dc.description.sponsorshipMINECO, Spanish Government of Economy and Competitiveness [AGL2013-45554-R]; CIBERobn; Instituto de Salud Carlos III; Center for Nutrition Research of the University of Navarraes_ES
dc.language.isoenges_ES
dc.publisherNCBIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectCirculating Micrornases_ES
dc.subjectCancer-Detectiones_ES
dc.subjectAdipose-Tissuees_ES
dc.subjectObesityes_ES
dc.subjectP53es_ES
dc.subjectAdipocyteses_ES
dc.subjectAtherosclerosises_ES
dc.subjectAdipogenesises_ES
dc.subjectMethylationes_ES
dc.subjectActivationes_ES
dc.titleImplication of miR-612 and miR-1976 in the regulation of TP53 and CD40 and their relationship in the response to specific weight-loss dietses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.description.noteThis is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.es_ES
dc.identifier.doi10.1371/journal.pone.0201217-
dadun.citation.number8es_ES
dadun.citation.publicationNamePlos Onees_ES
dadun.citation.startingPagee0201217es_ES
dadun.citation.volume13es_ES

Files in This Item:
Thumbnail
File
pone.0201217.pdf
Description
Size
2.46 MB
Format
Adobe PDF


Statistics and impact

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.